BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2455530)

  • 21. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.
    Kiyosawa K; Akahane Y; Nagata A; Furuta S
    Am J Gastroenterol; 1984 Oct; 79(10):777-81. PubMed ID: 6091443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma in Israel: relationship to hepatitis B virus infection.
    Yahalom J; Livni N; Fuks Z; Levij IS
    Isr J Med Sci; 1985 Jan; 21(1):1-5. PubMed ID: 2579047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
    Swenson PD; Escobar MR; Silverman JF
    Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia.
    Cohen C; DeRose PB
    Mod Pathol; 1994 Jun; 7(5):536-9. PubMed ID: 7937718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathology of liver cirrhosis and hepatocellular carcinoma. Recent studies by Japanese workers.
    Mori W; Machinami R
    Acta Pathol Jpn; 1982; 32 Suppl 1():133-43. PubMed ID: 6196936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
    Espinoza CG; Pillarisetti SG; Azar HA
    Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HBV DNA status and its correlation with HBsAg expression in hepatocellular carcinoma].
    Chen CX
    Zhonghua Yi Xue Za Zhi; 1988 Nov; 68(11):625-8, 44. PubMed ID: 2853990
    [No Abstract]   [Full Text] [Related]  

  • 29. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K
    J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
    Harada T; Shigeta K; Noda K; Fukumoto Y; Nishimura H; Mizuta M; Takemoto T
    Hepatogastroenterology; 1980 Jun; 27(3):169-75. PubMed ID: 6161869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
    Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of hepatitis Bs antigen titres and alpha foetoprotein levels in primary hepatocellular carcinoma in Kenya.
    Bowry TR; Shah MV
    East Afr Med J; 1980 Jun; 57(6):382--9. PubMed ID: 6156817
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].
    Feng Z; He R; Lu Z; Ling Y
    Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
    Chen DS; Sung FL
    Gastroenterology; 1978 Jan; 74(1):163-4. PubMed ID: 72701
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
    Volc-Platzer B; Hanak H; Weiss W; Denk H
    Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of hepatitis B virus with chronic liver diseases and hepatocellular carcinoma.
    Pati S; Patnaik S; Chawda S; Nanda BK
    Indian J Pathol Microbiol; 1989 Apr; 32(2):122-4. PubMed ID: 2553594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary hepatocarcinoma and hepatitis B virus in Sardinia].
    Lai ME; Faa G; Farci P; Liguori C; Figus A; Costa V; Balestrieri A
    Pathologica; 1988; 80(1068):443-8. PubMed ID: 2854232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.